MDPI and ACS Style
von Bredow, L.; Schäfer, T.M.; Hogenkamp, J.; Tretbar, M.; Stopper, D.; Kraft, F.B.; Schliehe-Diecks, J.; Schöler, A.; Borkhardt, A.; Bhatia, S.;
et al. Synthesis, Antiplasmodial, and Antileukemia Activity of Dihydroartemisinin–HDAC Inhibitor Hybrids as Multitarget Drugs. Pharmaceuticals 2022, 15, 333.
https://doi.org/10.3390/ph15030333
AMA Style
von Bredow L, Schäfer TM, Hogenkamp J, Tretbar M, Stopper D, Kraft FB, Schliehe-Diecks J, Schöler A, Borkhardt A, Bhatia S,
et al. Synthesis, Antiplasmodial, and Antileukemia Activity of Dihydroartemisinin–HDAC Inhibitor Hybrids as Multitarget Drugs. Pharmaceuticals. 2022; 15(3):333.
https://doi.org/10.3390/ph15030333
Chicago/Turabian Style
von Bredow, Lukas, Thomas Martin Schäfer, Julian Hogenkamp, Maik Tretbar, Daniel Stopper, Fabian B. Kraft, Julian Schliehe-Diecks, Andrea Schöler, Arndt Borkhardt, Sanil Bhatia,
and et al. 2022. "Synthesis, Antiplasmodial, and Antileukemia Activity of Dihydroartemisinin–HDAC Inhibitor Hybrids as Multitarget Drugs" Pharmaceuticals 15, no. 3: 333.
https://doi.org/10.3390/ph15030333